COLLABORATIVE DRUG DISCOVERY, INC.
Cloud-based informatics platform that integrates disparate databases and computational tools into custom drug discovery workflows
- Sector
- Software
- Total capital
- $11.7M
- Federal grants
- $11.7M
- 20 awards · 2015–2023
- Sector median 0 awards
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 7 pending · first 2017
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · A Robust, Secure Framework to Effortlessly Bind Distributed Databases and Analysis Tools into Tightly Integrated Translational Drug Discovery Computational Platforms$855K
- Federal grantHealth and Human S · Phase II · A Robust, Secure Framework to Effortlessly Bind Distributed Databases and Analysis Tools into Tightly Integrated Translational Drug Discovery Computational Platforms$855K
- Federal grantHealth and Human S · Phase II · Intelligent Chemical Structure Browser for Drug Discovery and Optimization$727K
- Federal grantHealth and Human S · Phase II · Intelligent Chemical Structure Browser for Drug Discovery and Optimization$727K
- Federal grantHealth and Human S · Phase II · Novel deep learning strategy to better predict pharmacological properties of candidate drugs and focus discovery efforts$750K
- Federal grantHealth and Human S · Phase II · Digital representation of chemical mixtures to aid drug discovery and formulation$751K
- Federal grantHealth and Human S · Phase II · Novel deep learning strategy to better predict pharmacological properties of candidate drugs and focus discovery efforts$750K
Show 13 earlier federal awards
- Federal grantHealth and Human S · Phase II · Digital representation of chemical mixtures to aid drug discovery and formulation$749K
- Federal grantHealth and Human S · Phase I · A Robust, Secure Framework to Effortlessly Bind Distributed Databases and Analysis Tools into Tightly Integrated Translational Drug Discovery Computational Platforms$150K
- Federal grantHealth and Human S · Phase I · Digital representation of chemical mixtures to aid drug discovery and formulation$55K
- Federal grantHealth and Human S · Phase I · Intelligent Chemical Structure Browser for Drug Discovery and Optimization$150K
- Federal grantHealth and Human S · Phase II · Comprehensive but simple encoding of bioassays to accelerate translational drug discovery$754K
- Federal grantHealth and Human S · Phase I · Novel deep learning strategy to better predict pharmacological properties of candidate drugs and focus discovery efforts$150K
- Federal grantHealth and Human S · Phase I · Digital representation of chemical mixtures to aid drug discovery and formulation$149K
- Federal grantHealth and Human S · Phase II · Biocomputation across distributed private datasets to enhance drug discovery$749K
- Federal grantHealth and Human S · Phase II · Comprehensive but simple encoding of bioassays to accelerate translational drug discovery$744K
- Federal grantHealth and Human S · Phase II · Biocomputation across distributed private datasets to enhance drug discovery$750K
- Federal grantHealth and Human S · Phase II · Simplifying encoding of bioassays to accelerate translational drug discovery$739K
- Federal grantHealth and Human S · Phase II · Biocomputation across distributed private datasets to enhance drug discovery$379K
- Federal grantHealth and Human S · Phase II · Simplifying encoding of bioassays to accelerate translational drug discovery$751K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 8- PendingSystems And Methods For Identifying Lead Chemical Compounds Based On Reproduced Order-dependent Representations Of A Chemical CompoundUSPTOApplication 18312620
- PendingSystems And Methods For Generating Reproduced Order- Dependent Representations Of A Chemical CompoundUSPTOApplication 17709614
- PendingSystems And Methods For Generating And Searching A Chemical Compound DatabaseUSPTOApplication 17196420
Show all 8 patent records
- Systems And Methods For Identifying Lead Chemical Compounds Based On Reproduced Order-dependent Representations Of A Chemical CompoundNov 9, 2023 · Application 18312620Pending
- Systems And Methods For Generating Reproduced Order- Dependent Representations Of A Chemical CompoundOct 13, 2022 · Application 17709614Pending
- Systems And Methods For Generating And Searching A Chemical Compound DatabaseSep 16, 2021 · Application 17196420Pending
- Hybrid Machine-user Learning System And Process For Identifying, Accurately Selecting And Storing Scientific DataMar 14, 2017 · US 9,594,743Granted
- Deep Learning Drug DiscoveryApplication 63172303Pending
- End-to-end GenerationApplication 63338487Pending
- Intelligent Chemistry BrowserApplication 62989008Pending
- Hybrid Machine-user Learning System And Process For Identifying, Accurately Selecting And Storing Scientific DataApplication 62029220Pending
Recent research by its founders
- Automated QSAR — how good is it in practice?20260 cites
- Characterizing and Exploiting the Latent Space of a Graph Convolutional Network for Bioisostere Identification20260 cites
- Development of log P and log D models using a hierarchical linear regression approach20260 cites
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .